Blaze™ Microchip System for Real-Time Characterization of Intact Biotherapeutics
The Blaze™ System accelerates biotherapeutic development by directly coupling imaged cIEF charge variant analysis with high-resolution MS detection for intact proteins. Blaze enables the identification of post-translational modifications that can undermine the safety and efficacy of biotherapeutic drugs. Even better, Blaze does it all in 15 minutes per sample, not days or weeks. With Blaze, scientists can make better, more informed decisions sooner while maintaining high product quality AND speed in their development programs.